Bank of America’s Maravai LifeSciences MRVI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.48M | Buy |
1,029,645
+151,205
| +17% | +$364K | ﹤0.01% | 3851 |
|
|
2025
Q1 | $1.94M | Buy |
878,440
+189,258
| +27% | +$418K | ﹤0.01% | 3947 |
|
|
2024
Q4 | $3.76M | Sell |
689,182
-205,292
| -23% | -$1.12M | ﹤0.01% | 3258 |
|
|
2024
Q3 | $7.43M | Sell |
894,474
-139,560
| -13% | -$1.16M | ﹤0.01% | 2871 |
|
|
2024
Q2 | $7.4M | Sell |
1,034,034
-259,974
| -20% | -$1.86M | ﹤0.01% | 2792 |
|
|
2024
Q1 | $11.2M | Buy |
1,294,008
+753,702
| +139% | +$6.53M | ﹤0.01% | 2463 |
|
|
2023
Q4 | $3.54M | Sell |
540,306
-654,087
| -55% | -$4.28M | ﹤0.01% | 3187 |
|
|
2023
Q3 | $11.9M | Buy |
1,194,393
+57,297
| +5% | +$573K | ﹤0.01% | 2182 |
|
|
2023
Q2 | $14.1M | Buy |
1,137,096
+670,007
| +143% | +$8.33M | ﹤0.01% | 2014 |
|
|
2023
Q1 | $6.54M | Buy |
467,089
+287,434
| +160% | +$4.03M | ﹤0.01% | 2778 |
|
|
2022
Q4 | $2.57M | Buy |
179,655
+76,126
| +74% | +$1.09M | ﹤0.01% | 3472 |
|
|
2022
Q3 | $2.64M | Sell |
103,529
-109,902
| -51% | -$2.81M | ﹤0.01% | 3428 |
|
|
2022
Q2 | $6.06M | Sell |
213,431
-189,148
| -47% | -$5.37M | ﹤0.01% | 2735 |
|
|
2022
Q1 | $14.2M | Sell |
402,579
-41,973
| -9% | -$1.48M | ﹤0.01% | 2179 |
|
|
2021
Q4 | $18.6M | Sell |
444,552
-25,455
| -5% | -$1.07M | ﹤0.01% | 1970 |
|
|
2021
Q3 | $23.1M | Buy |
470,007
+34,792
| +8% | +$1.71M | ﹤0.01% | 1784 |
|
|
2021
Q2 | $18.2M | Buy |
435,215
+374,687
| +619% | +$15.6M | ﹤0.01% | 1963 |
|
|
2021
Q1 | $2.16M | Sell |
60,528
-32,885
| -35% | -$1.17M | ﹤0.01% | 3681 |
|
|
2020
Q4 | $2.62M | Buy |
+93,413
| New | +$2.62M | ﹤0.01% | 3201 |
|